AMYT · Amryt Pharma
Acquired Company
Chiesi Farmaceutici S.p.A. completed the acquisition of Amryt Pharma Plc on 4/12/2023 for US$14.50 per ADS plus Contingent Value Rights of up to US$2.50 per ADS, representing a total transaction value of up to US$1.48 billion.
Amryt Pharma PLC operates as a biopharmaceutical company. The Company develops and delivers treatments for rare and orphan diseases. Amryt Pharma serves customers worldwide.
Dept, Woodgreen Underground Station, London, N22 8HH, United Kingdom
Pharmaceutical Preparation Manufacturing
Manufacturing
Market Cap
N/A
52 Wk Range
N/A - N/A
Previous Close
$14.70
Open
$14.70
Volume
N/A
Day Range
$14.70 - $14.70
Enterprise Value
N/A
Cash
N/A
Avg Qtr Burn
N/A
Insider Ownership
0.08%
Institutional Own.
77.31%
Qtr Updated
Jun 30th 2024